"CONCLUSIONS
We estimated that screening for lung cancer with low-dose CT would cost $81,000 per QALY gained, but we also determined that modest changes in our assumptions would greatly alter this figure. The determination of whether screening outside the trial will be cost-effective will depend on how screening is implemented. (Funded by the National Cancer Institute; NLST ClinicalTrials.gov number,NCT00047385.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1312547?query=featured_home
No comments:
Post a Comment